ArticleCancers2023

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer.

Zin W Myint et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.